HomeGLUE • NASDAQ
Monte Rosa Therapeutics Inc
add
$4.63
3.12%
After Hours:(0.00%)0.00
$4.63
Closed: Jun 20, 4:03:22 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 84.93M | 7,882.05% |
Operating expense | 40.89M | 13.56% |
Net income | 46.89M | 246.66% |
Net profit margin | 55.20 | 101.84% |
Earnings per share | 0.57 | 207.55% |
EBITDA | 46.08M | 239.44% |
Effective tax rate | 1.72% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 326.07M | 69.04% |
Total assets | 393.20M | 47.41% |
Total liabilities | 118.04M | 3.34% |
Total equity | 275.16M | — |
Shares outstanding | 61.51M | — |
Price to book | 1.00 | — |
Return on assets | 26.47% | — |
Return on capital | 37.79% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 46.89M | 246.66% |
Cash from operations | -45.49M | -19.20% |
Cash from investing | -100.23M | -1,117.24% |
Cash from financing | 14.00K | -94.31% |
Net change in cash | -145.71M | -419.16% |
Free cash flow | -64.91M | -176.43% |
Previous close
$4.49
Day range
$4.37 - $4.66
Year range
$3.21 - $12.40
Market cap
284.79M USD
Avg Volume
453.98K
P/E ratio
373.69
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2019
Headquarters
Website
Employees
142
